Public trial registry of the CCC-Munich

Trial GOAL

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
GOAL
World
Full title
:

Rescue-Behandlung mit dem monoklonalen Anti-CD20-Antikörper Obinutuzumab (GA101) in
Kombination mit PixantrOne zur Behandlung von Patienten mit rezidivierenden aggressiven B-Zellen
Lymphom
GA101 plus Pixantrone für rezidiviertes aggressives Lymphom

World
Description
:

Rescue treatment with the monoclonal anti CD20-antibody Obinutuzumab (GA101) in
combination with PixantrOne for the treatment of patients with relapsed Aggressive B-cell
Lymphoma
GA101 plus Pixantrone for relapsed aggressive Lymphoma

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Indications
Classification Code Description
ICD-10-GM C83.3 Diffuses großzelliges B-Zell-Lymphom
ICD-10-GM C85.1 B-Zell-Lymphom, nicht näher bezeichnet
- Lymphoma
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
II
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2021-12-31 / Unknown
Therapy
World
Therapy line
:
2
Participants
Function Prename Surname Organization
World Principal Investigator MARTIN DREYLING Keine Organisationseinheit angegeben Magnifier
World Responsible contact Marta Illenyi Keine Organisationseinheit angegeben Magnifier